Evansville Cancer Center/Vantage Oncology Hosts Free Prostate Screening Event on November 8th
October 30, 2012 - Evansville Cancer Center/Vantage Oncology (ECC/VO) and its co-sponsors Therapy Associations, and Deaconess Health Systems in partnership with area urologists are hosting a free prostate cancer screening event on Thursday, November 8th from 5 p.m. to 7 p.m. The screenings will take place at ECC/VO located on 706 North Burkhardt Road in Evansville. The results are strictly confidential and will be mailed directly to participants.
The prostate screening involves a Prostate-Specific Antigen (PSA) blood test and Digital Rectal Exam (DRE) that are provided by board certified urologists Dr. Todd Renschler and Dr. Thomas Gadient of Urological Associates and Dr. Charles Vincent of Deaconess Clinic Urology, as well as radiation oncologists Dr. Jon D. Frazier and Dr. Noah Taylor and medical oncologist Dr. Rick Ballou of ECC/VO. Men 50 years of age or older who have never received a prostate cancer diagnosis or treatment and have not had a PSA test or DRE exam in the past year are encouraged to attend. The decision to participate in a screening for early detection of prostate cancer should be between the individual and their primary care physician or urologist. A positive or rise in the PSA does not automatically mean the individual needs a biopsy or that he has been diagnosed with prostate cancer.
The American Cancer Society (ACS) estimates that in 2012, 241,740 men will be diagnosed with prostate cancer and 28,170 will lose their lives to it. Prostate cancer is the second leading cause of cancer death in American men, behind only lung cancer. Prostate cancer can be a serious disease, but most men diagnosed with prostate cancer do not die from it. In fact, more than 2.5 million men in the United States who have been diagnosed with prostate cancer at some point are still alive today.
The ACS’ website identifies numerous risk factors, signs and symptoms and important prevention tips regarding prostate cancer and they include the following:
Age: Prostate cancer is very rare in men younger than 40, but the chance of having prostate cancer rises rapidly after age 50. Almost 2 out of 3 prostate cancers are found in men over the age of 65.
Race and Ethnicity: Prostate cancer occurs more often in African-American men than in men of other races, and are more than twice as likely to die of prostate cancer as white men.
Family History: Having a father or brother with prostate cancer more than doubles a man's risk of developing this disease.
Genes: Scientists have found several inherited gene changes that seem to raise prostate cancer and some common gene variations are linked to a higher risk of the disease.
Diet: Men who eat a lot of red meat or high-fat dairy products appear to have a slightly higher chance of getting prostate cancer.
Obesity: Some studies have found that obese men may be at greater risk for having more advanced prostate cancer and of dying from prostate cancer.
ECC/VO is reminding patients that early detection can significantly improve treatment outcomes for those diagnosed. “We continue to make tremendous strides in the detection and treatment of prostate cancer. However, these advancements are for naught if we can’t convince men to visit their doctor to receive an annual screening,” said Jon D. Frazier, M.D., radiation oncologist and medical director of ECC/VO.
For more information about the event, please call Robin Lawrence at (812) 474-6000 or Patty at (812) 253-9110